Freedom-to-Practice: Oncology Drug

Steven J. Goldstein and Karlyn A. Schnapp provided numerous patent freedom-to-practice and invalidity opinions to support ANDA filings of a major generic pharmaceutical company, including a first to file ANDA filing for an oncology drug.